Background and Format: The Pharmaceutical Journal is published by the Royal Pharmaceutical Society monthly and aimed at community pharmacists, pharmaceutical scientists, independent prescribers, hospital pharmacists, pharmacy students, technicians, industrial pharmacists, pre-registration trainees, regulatory pharmacists, academics, pharmacy owners, healthcare policy makers and other healthcare professionals. Covers news & analysis, learning, research, comment, books & art and careers. It also has sister publications Clinical Pharmacist and Tomorrow's Pharmacist. The media pack is available from: http://www.pharmaceutical-journal.com/services/advertise/#reach Circulation: Source: Publisher   Alerts: Gorkana UK Financial Alert: Monday 2nd November 2015 The Pharmaceutical Journal, the official journal of the Royal Pharmaceutical Society, which caters for pharmacists and pharmaceutical scientists, is relaunching from a 32-page publication 40 times per year, into a new 64-page publication 12 times per year. The journal will continue to cover news, analysis, features, opinion, learning and careers articles, providing insight and knowledge about drugs, pharmacy practice, medicines use and healthcare policy in the context of the pharmacy profession and pharmaceutical sciences. The Pharmaceutical Journal’s sister publication Clinical Pharmacist has increased frequency from 10 to 12 issues. Starting January 2016 it will publish peer-reviewed review, perspective and evidence-based CPD articles on topics from drug discovery to clinical pharmacology and pharmacy. It will also carry practice reports on best practice in pharmacy and pharmaceutical sciences. The site, which will remain updated daily, can be viewed at www.pharmaceutical-journal.com. News and Views Editor Harriet Adcock can be reached at harriet.adcock@pharmaceutical-journal.com and Deputy News Editor Elizabeth Sukkar can be reached at elizabeth.sukkar@pharmaceutical-journal.com Gorkana Alert: Monday 21 July 2014 The Pharmaceutical Journal, the official journal of the Royal Pharmaceutical Society, which caters for Pharmacists and Pharmaceutical Scientists, launched a new website and print magazine this month. The journal covers news, features and articles on pharmacy, healthcare policy and clinical science. The editorial team welcomes freelance contributors for news and features. The site can be viewed at www.pharmaceutical-journal.com. News Editor Harriet Adcock can be reached at harriet.adcock@pharmaceutical-journal.com and Deputy News Editor Elizabeth Sukkar can be reached at elizabeth.sukkar@pharmaceutical-journal.com Gorkana Alert: Wednesday 22 August 2012 Ayshe Ismail, previously the Editorial Assistant at The Pharmaceutical Journal, has left. The Pharmaceutical Journal is the official journal of the Royal Pharmaceutical Society and aims to provide comprehensive news coverage on all aspects of pharmacy and to publish original research and articles on pharmaceutical and related subject

Future Science Group is to serve the advancement of clinical practice and drug research by enhancing the efficiency of communication among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs

Established in 1981 and written for biotech and biopharma professionals involved in research, technical and commercial management. Provides coverage of biotechnology news and developments, scale-up and bioprocess technologies, regulatory and legal issues, new products and R&D and novel drug discovery techniques. Also includes financial news (public offerings, mergers and venture capital investments), funding and government news, corporate profiles, university news, meeting reports, international round-ups and literature information and articles relating to research projects and the production of biotechnology products.Regular topics in the publication include drug discovery technologies and R&D, trends in instrumentation, genomics and downstream omics, gene therapy, industrial biotechnology, enzymes, bioprocessing strategies, contract manufacture, monoclonal antibodies, bioinformatics, cell culture, LIMS, business issues and regulatory issues.Features the channels: Biobusiness which covers financial, business or patent related; Drug Discovery handles technical issues related to early stages of research and finding new pharmaceuticals; Omics spotlights genomics, proteomics and technologies such as metabolomics and Translational Medicine focuses on clinical and scientific efforts that concerns research and clinical settings. Other sections: Podcasts; Blogs; New Products; Best of the Web; GEN Updates RNAi; Oligonucleotides; Next-Generation Sequencing; Jobs; Classified Mart Marketplace; Real Estate; Conferences/Meetings; and Biotech Companies.The site offers RSS (Really Simple Syndication) and a digital Podcast.The publication DOES accept article submissions. Articles should be submitted to Managing Editor. Articles can be submitted either as POV articles, tutorials, overviews for the Transitional Medicine section, or online. For POV articles, they should be submitted one to two months in advance and should be about 1000 words. For tutorials, the articles should be submitted 4-6 months in advance and should be 1000-12000 words. For the Transitional Medicine section, these articles should be overviews, as opposed to specific points of view. They should also be 1000 words. For the online perspectives, they should be submitted a week before.

Established in 2000 as Oncology Net Guide and rebranded in March 2011 as OncLive. Written for physicians to enable them to keep up to date with the rapidly expanding amount of medical information and resources on oncology. Designed as a handbook for frequent referencing and written in an easy-to-understand style. Articles are quick-reading, timely, provides practical information and information about new medical treatments. Media Alert: Tuesday April 12th 2011 Oncology Net Guide has changed its name to OncLive. Anita Shaffer is Associate Editor in charge of the oncology research and technology magazine. She may be reached at +1 (609) 716 7777 Ext 192 and ashaffer@onclive.com

Publishes research into the molecular and cellular basis of normal physiology and disease. Written for and by physician-scientists, and contains news and information on current biomedical research. Articles pertain to the genetic, cellular, molecular or physiological aspects of human disease.